Archon Biosciences

Archon Biosciences is a biotechnology company developing computationally designed proteins to unlock powerful therapeutic targets that are unreachable by existing methods and to better treat diseases. Archon directly applies generative protein design to rapidly produce Antibody Cages (AbC), a new class of biologics with unique potency and differentiated biodistribution. AbC integrates the unparalleled binding affinity and specificity of antibodies into novel self-assembling nanostructures, aiming to overcome the most challenging obstacles in drug development.